Abstract
Computational neuroanatomy based on magnetic resonance imaging (MRI) provides a framework for in vivo assessment of brain structure in movement disorders, demonstrating diagnostic potential in early clinical stages next to ability to monitor therapy effects, and/or disease progression. Recent methodological developments in MR physics and data analysis have brought further insight into the pathophysiology of neurological disorders. Volume-, shape-, and surface-based computational neuroanatomy techniques allow for sensitive and reliable differentiation of phenotype–genotype-related traits and their interaction even at presymptomatic stages of disease. Analysis of multiparameter MR data sheds light on specific brain tissue property changes linking noninvasive imaging with the pathophysiology of a particular movement disorder. Given the steadily growing number of MRI-based computational neuroanatomy studies in movement disorders, this chapter can only focus on major themes within the published literature. The first section of this chapter outlines recent advances in MR data acquisition, processing, and analysis touching on general principles of computational neuroanatomy followed by a section on morphometry in specific movement disorders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol. 2003;2(2):79–88.
Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996;111(3):209–19.
Helms G, Dathe H, Kallenberg K, Dechent P. High-resolution maps of magnetization transfer with inherent correction for RF inhomogeneity and T1 relaxation obtained from 3D FLASH MRI. Magn Reson Med. 2008;60(6):1396–407.
Helms G, Finsterbusch J, Weiskopf N, Dechent P. Rapid radiofrequency field mapping in vivo using single-shot STEAM MRI. Magn Reson Med. 2008;60(3):739–43.
Helms G, Draganski B, Frackowiak R, Ashburner J, Weiskopf N. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. Neuroimage. 2009;47(1):194–8.
Ashburner J. Computational anatomy with the SPM software. Magn Reson Imaging. 2009;27(8):1163–74.
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9(2):179–94.
Klöppel S, Draganski B, Golding CV, et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington’s disease. Brain. 2008;131(Pt 1):196–204.
Klöppel S, Chu C, Tan GC, et al. Automatic detection of preclinical neurodegeneration: presymptomatic Huntington’s disease. Neurology. 2009;72(5):426–31.
Kherif F, Josse G, Seghier ML, Price CJ. The main sources of intersubject variability in neuronal activation for reading aloud. J Cogn Neurosci. 2009;21(4):654–68.
Kawasaki Y, Suzuki M, Kherif F, et al. Multivariate voxel-based morphometry succesfully differentiates schizophrenia patients from healthy controls. Neuroimage. 2007;34(1):235–42.
Huber SJ, Shuttleworth EC, Christy JA, Chakeres DW, Curtin A, Paulson GW. Magnetic resonance imaging in dementia of Parkinson’s disease. J Neurol Neurosurg Psychiatr. 1989;52(11):1221–7.
Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: an MRI study. Neurology. 1996;46(3):678–81.
Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson’s disease with measures of cognitive decline. J Neural Transm. 2001;108(5):571–80.
Pereira JB, Ibarretxe-Bilbao N, Marti M-J, et al. Assessment of cortical degeneration in patients with Parkinson’s disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp. 2012;33(11):2521–34.
Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s disease. Mov Disord. 2011;26(9):1633–8.
Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm. 1988;74(3):199–205.
Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in postmortem parkinsonian brain. Lancet. 1987;2(8569):1219–20.
Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 1991;114(Pt 4):1953–75.
Graham JM, Paley MN, Grünewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain. 2000;123(Pt 12):2423–31.
Martin WRW, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology. 2008;70(16 Pt 2):1411–7.
Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuroreport. 2006;17(11):1215–8.
Menke RA, Scholz J, Miller KL, et al. MRI characteristics of the substantia nigra in Parkinson’s disease: a combined quantitative T1 and DTI study. Neuroimage. 2009;47(2):435–41.
Vaillancourt DE, Spraker MB, Prodoehl J, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. 2009;72(16):1378–84.
Du G, Lewis MM, Styner M, et al. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson’s disease. Mov Disord. 2011;26(9):1627–32.
Lyoo CH, Ryu YH, Lee MS. Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson’s disease. J Neurol. 2011;258(10):1871–6.
Kassubek J, Juengling FD, Hellwig B, Spreer J, Lücking CH. Thalamic grey matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett. 2002;323(1):29–32.
Amboni M, Cozzolino A, Longo K, Picillo M, Barone P. Freezing of gait and executive functions in patients with Parkinson’s disease. Mov Disord. 2008;23(3):395–400.
Kostic VS, Agosta F, Pievani M, et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology. 2012;78(6):409–16.
Kostić VS, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology. 2010;75(10):857–63.
Blood AJ, Iosifescu DV, Makris N, et al. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS ONE. 2010;5(11):e13945.
Kim JW, Lee DY, Choo IH, et al. Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease. Am J Geriatr Psychiatry. 2011;19(7):644–53.
Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–9; quiz 313.
Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT. Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain. 2004;127(Pt 4):791–800.
Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol. 2011;68(12):1562–8.
Apostolova LG, Beyer M, Green AE, et al. Hippocampal, caudate, and ventricular changes in Parkinson’s disease with and without dementia. Mov Disord. 2010;25(6):687–95.
Dalaker TO, Larsen JP, Bergsland N, et al. Brain atrophy and white matter hyperintensities in early Parkinson’s disease(a). Mov Disord. 2009;24(15):2233–41.
Dalaker TO, Larsen JP, Dwyer MG, et al. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson’s disease. Neuroimage. 2009;47(4):2083–9.
Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatr. 2007;78(3):254–9.
Bouchard TP, Malykhin N, Martin WRW, et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson’s disease. Neurobiol Aging. 2008;29(7):1027–39.
Martin WRW, Wieler M, Gee M, Camicioli R. Temporal lobe changes in early, untreated Parkinson’s disease. Mov Disord. 2009;24(13):1949–54.
Camicioli R, Gee M, Bouchard TP, et al. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. Parkinsonism Relat Disord. 2009;15(3):187–95.
Lyoo CH, Ryu YH, Lee MS. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson’s disease without dementia. Mov Disord. 2010;25(4):496–9.
Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy bodies and Parkinson’s disease with dementia. Mov Disord. 2009;24(12):1740–6.
Lee JE, Park H-J, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson’s disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatr. 2010;81(3):320–6.
Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211.
Wattendorf E, Welge-Lüssen A, Fiedler K, et al. Olfactory impairment predicts brain atrophy in Parkinson’s disease. J Neurosci. 2009;29(49):15410–3.
Rolheiser TM, Fulton HG, Good KP, et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol. 2011;258(7):1254–60.
Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2009;30(6):1222–6.
Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol. 2008;29(3):501–5.
Jubault T, Brambati SM, Degroot C, et al. Regional brain stem atrophy in idiopathic Parkinson’s disease detected by anatomical MRI. PLoS ONE. 2009;4(12):e8247.
Colosimo C, Riley DE, Wenning GK. Handbook of atypical Parkinsonism. Cambridge: Cambridge University Press; 2011.
Stamelou M, Knake S, Oertel WH, Höglinger GU. Magnetic resonance imaging in progressive supranuclear palsy. J Neurol. 2011;258(4):549–58.
Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007;17(1):74–82.
Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatr. 2004;75(2):246–9.
Price S, Paviour D, Scahill R, et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. Neuroimage. 2004;23(2):663–9.
Ling H, O’Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain. 2010;133(Pt 7):2045–57.
Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63(1):81–6.
Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging. 2008;29(2):280–9.
Rizzo G, Martinelli P, Manners D, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson’s disease. Brain. 2008;131(Pt 10):2690–700.
Minnerop M, Specht K, Ruhlmann J, et al. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage. 2007;36(4):1086–95.
Brenneis C, Egger K, Scherfler C, et al. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol. 2007;254(2):191–6.
Tsukamoto K, Matsusue E, Kanasaki Y, et al. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson’s disease: evaluation by 3.0-T MR imaging. Neuroradiology. 2012;54(9):947–55.
Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. 2008;246(1):214–21.
Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson’s syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol. 1999;45(1):65–74.
Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol. 2001;58(7):1076–9.
Focke NK, Helms G, Pantel PM, et al. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. AJNR Am J Neuroradiol. 2011;32(11):2087–92.
Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. Brain. 1985;108(Pt 2):463–83.
Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117(Pt 4):859–76.
Guehl D, Cuny E, Ghorayeb I, Michelet T, Bioulac B, Burbaud P. Primate models of dystonia. Progress in Neurobiology. 2009;87(2):118–31.
Black KJ, Ongür D, Perlmutter JS. Putamen volume in idiopathic focal dystonia. Neurology. 1998;51(3):819–24.
Etgen T, Mühlau M, Gaser C, Sander D. Bilateral grey-matter increase in the putamen in primary blepharospasm. J Neurol Neurosurg Psychiatr. 2006;77(9):1017–20.
Bradley D, Whelan R, Walsh R, et al. Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia. Brain. 2009;132(Pt 9):2327–35.
Obermann M, Yaldizli O, De Greiff A, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord. 2007;22(8):1117–23.
Pantano P, Totaro P, Fabbrini G, et al. A transverse and longitudinal MR imaging voxel-based morphometry study in patients with primary cervical dystonia. AJNR Am J Neuroradiol. 2011;32(1):81–4.
Egger K, Mueller J, Schocke M, et al. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Mov Disord. 2007;22(11):1538–42.
Granert O, Peller M, Jabusch H-C, Altenmüller E, Siebner HR. Sensorimotor skills and focal dystonia are linked to putaminal grey-matter volume in pianists. J Neurol Neurosurg Psychiatr. 2011;82(11):1225–31.
Neychev VK, Gross RE, Lehéricy S, et al. The functional neuroanatomy of dystonia. Neurobiol Dis. 2011;42(2):185–201.
Draganski B, Thun-Hohenstein C, Bogdahn U, Winkler J, May A. “Motor circuit” gray matter changes in idiopathic cervical dystonia. Neurology. 2003;61(9):1228–31.
Draganski B, Schneider SA, Fiorio M, et al. Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. Neuroimage. 2009;47(4):1141–7.
Garraux G, Bauer A, Hanakawa T, Wu T, Kansaku K, Hallett M. Changes in brain anatomy in focal hand dystonia. Ann Neurol. 2004;55(5):736–9.
Delmaire C, Vidailhet M, Elbaz A, et al. Structural abnormalities in the cerebellum and sensorimotor circuit in writer’s cramp. Neurology. 2007;69(4):376–80.
Delmaire C, Vidailhet M, Wassermann D, et al. Diffusion abnormalities in the primary sensorimotor pathways in writer’s cramp. Arch Neurol. 2009;66(4):502–8.
Colosimo C, Pantano P, Calistri V, Totaro P, Fabbrini G, Berardelli A. Diffusion tensor imaging in primary cervical dystonia. J Neurol Neurosurg Psychiatr 2005;76(11):1591–3.
Fabbrini G, Pantano P, Totaro P, et al. Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm. Eur J Neurol. 2008;15(2):185–9.
Sadnicka A, Hoffland BS, Bhatia KP, van de Warrenburg BP, Edwards MJ. The cerebellum in dystonia—help or hindrance? Clin Neurophysiol. 2012;123(1):65–70.
Ozelius LJ, Bressman SB. Genetic and clinical features of primary torsion dystonia. Neurobiol Dis. 2011;42(2):127–35.
Meunier S, Lehéricy S, Garnero L, Vidailhet M. Dystonia: lessons from brain mapping. Neuroscientist. 2003;9(1):76–81.
Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci. 2009;29(31):9740–7.
Walker FO. Huntington’s disease. Lancet. 2007;369(9557):218–28.
Aylward E, Mills J, Liu D, et al. Association between age and striatal volume stratified by CAG repeat length in prodromal Huntington’s disease. PLoS Curr. 2011;3:RRN1235.
Klöppel S, Henley SM, Hobbs NZ, et al. Magnetic resonance imaging of Huntington’s disease: preparing for clinical trials. Neuroscience. 2009;164(1):205–19.
Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F. Longitudinal analysis of regional grey matter loss in Huntington’s disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry. 2008;79(2):130–5.
Rosas HD, Reuter M, Doros G, et al. A tale of two factors: what determines the rate of progression in Huntington’s disease? A longitudinal MRI study. Movement Disorders. 2011;26(9):1691–7.
Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington’s disease: complexity and heterogeneity. Brain. 2008;131(Pt 4):1057–68.
Douaud G, Behrens TE, Poupon C, et al. In vivo evidence for the selective subcortical degeneration in Huntington’s disease. NeuroImage. 2009;46(4):958–66.
Rosas HD, Lee SY, Bender AC, et al. Altered white matter microstructure in the corpus callosum in Huntington’s disease: implications for cortical “disconnection.” Neuroimage. 2010;49(4):2995–3004.
Majid DSA, Stoffers D, Sheldon S, et al. Automated structural imaging analysis detects premanifest Huntington’s disease neurodegeneration within 1 year. Movement Disorders. 2011;26(8):1481–8.
Mandelli ML, Savoiardo M, Minati L, et al. Decreased diffusivity in the caudate nucleus of presymptomatic Huntington’s’s disease gene carriers: which explanation? AJNR Am J Neuroradiol. 2010;31(4):706–10.
Soneson C, Fontes M, Zhou Y, et al. Early changes in the hypothalamic region in prodromal Huntington’s disease revealed by MRI analysis. Neurobiol Dis. 2010;40(3):531–43.
Nopoulos PC, Aylward EH, Ross CA, et al. Cerebral cortex structure in prodromal Huntington’s disease. Neurobiol Dis. 2010;40(3):544–54.
Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington’s disease: evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137–42.
Jurgens CK, Bos R, Luyendijk J, et al. Magnetization transfer imaging in “premanifest” Huntington’s disease. J Neurol. 2010;257(3):426–32.
Rosas HD, Chen YI, Doros G, et al. Alterations in brain transition metals in Huntington’s disease: an evolving and intricate story. Arch Neurol. 2012;69(7):887–93.
Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain. 2000;123(Pt 8):1568–80.
Louis ED, Vonsattel JPG. The emerging neuropathology of essential tremor. Mov Disord. 2008;23(2):174–82.
Quattrone A, Cerasa A, Messina D, et al. Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. AJNR Am J Neuroradiol. 2008;29(9):1692–7.
A Cerasa, Messina D, Nicoletti G, et al. Cerebellar atrophy in essential tremor using an automated segmentation method. AJNR Am J Neuroradiol. 2009;30(6):1240–3.
Klein JC, Lorenz B, Kang J-S, et al. Diffusion tensor imaging of white matter involvement in essential tremor. Hum Brain Mapp. 2011;32(6):896–904.
Saini J, Bagepally BS, Bhatt MD, et al. Diffusion tensor imaging: tract based spatial statistics study in essential tremor. Parkinsonism Relat Disord. 2012;18(5):477–82.
Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487–505.
Louis ED. Essential tremors: a family of neurodegenerative disorders? Arch Neurol. 2009;66(10):1202–8.
Benito-León J, Alvarez-Linera J, Hernández-Tamames JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Louis ED. Brain structural changes in essential tremor: voxel-based morphometry at 3-T. J Neurol Sci. 2009;287(1-2):138–142.
Bagepally BS, Bhatt MD, Chandran V, et al. Decrease in cerebral and cerebellar gray matter in essential tremor: a voxel-based morphometric analysis under 3T MRI. J Neuroimaging. 2012;22(3):275–8.
Peterson BS, Staib L, Scahill L, et al. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry. 2001;58(5):427–40.
Draganski B, Martino D, Cavanna AE, et al. Multispectral brain morphometry in Tourette syndrome persisting into adulthood. Brain. 2010;133(Pt 12):3661–75.
Ludolph AG, Juengling FD, Libal G, Ludolph AC, Fegert JM, Kassubek J. Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry. 2006;188(5):484–5.
Müller-Vahl KR, Kaufmann J, Grosskreutz J, Dengler R, Emrich HM, Peschel T. Prefrontal and anterior cingulate cortex abnormalities in Tourette syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neuroscience. 2009;10(1):47.
Worbe Y, Gerardin E, Hartmann A, et al. Distinct structural changes underpin clinical phenotypes in patients with Gilles de La Tourette syndrome. Brain. 2010;133(12):3649–60.
O’Doherty JP, Hampton A, Kim H. Model-based fMRI and its application to reward learning and decision making. Ann N Y Acad Sci. 2007;1104(1):35–53.
Wittfoth M, Bornmann S, Peschel T, et al. Lateral frontal cortex volume reduction in Tourette syndrome revealed by VBM. BMC Neurosci. 2012;13:17.
van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132(Pt 4):853–68.
Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35(1):4–26.
Ramus SJ, Davis JB, Donahue RJ, Diszenca CB, Waite AA. Interactions between the orbitofrontal cortex and the hippocampal memory system during the storage of long-term memory. Ann N Y Acad Sci. 2007;1121(1):216–31.
Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev Neurosci. 2001;2(6):417–24.
Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology. 2005;65(8):1253–8.
Peterson BS, Thomas P, Kane MJ, et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch General Psychiatry. 2003;60(4):415.
Peterson B, Riddle MA, Cohen DJ, et al. Reduced basal ganglia volumes in Tourette’s syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology. 1993;43(5):941–9.
Makki MI, Govindan RM, Wilson BJ, Behen ME, Chugani HT. Altered fronto-striato-thalamic connectivity in children with Tourette syndrome assessed with diffusion tensor MRI and probabilistic fiber tracking. J Child Neurol. 2009;24(6):669–78.
Wheeler-Kingshott CAM, Cercignani M. About “axial” and “radial” diffusivities. Magnet Reson Med. 2009;61(5):1255–60.
Ferretti A, Babiloni C, Gratta CD, et al. Functional topography of the secondary somatosensory cortex for nonpainful and painful stimuli: an fMRI study. Neuroimage. 2003;20(3):1625–38.
Fahim C, Yoon U, Das S, et al. Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex. 2010;46(6):750–60.
Sowell ER, Kan E, Yoshii J, et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci. 2008;11(6):637–9.
Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nat Rev Neurol. 2012;8(4):203–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Draganski, B., Accolla, E. (2013). Morphometric Analyses in Movement Disorders. In: Nahab, F., Hattori, N. (eds) Neuroimaging of Movement Disorders. Current Clinical Neurology, vol 44. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-471-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-471-5_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-470-8
Online ISBN: 978-1-62703-471-5
eBook Packages: MedicineMedicine (R0)